Longwood Capital Partners »

Celldex Therapeutics shares owned by Longwood Capital Partners

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Longwood Capital Partners from 13F filings

Historical chart of Longwood Capital Partners investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Longwood Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Longwood Capital Partners

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.4M 122k 27.52
2023-06-30 $4.2M 122k 33.93
2023-03-31 $4.4M 122k 35.98
2022-12-31 $5.1M 115k 44.57
2022-09-30 $7.5M 267k 28.11
2022-06-30 $7.2M 267k 26.96
2022-03-31 $11M 323k 34.06
2021-12-31 $13M 340k 38.64
2021-09-30 $18M 338k 53.99
2021-06-30 $50M 1.5M 33.44
2021-03-31 $21M 1.0M 20.60
2020-12-31 $29M 1.6M 17.52
2020-09-30 $23M 1.5M 14.83
2020-06-30 $13M 1.0M 13.00